Recent advances in nanoparticle formulation of oleanolic acid

被引:79
作者
Chen, Meiwan [1 ]
Zhong, Zhangfeng [1 ]
Tan, Wen [1 ]
Wang, Shengpeng [1 ]
Wang, Yitao [1 ]
机构
[1] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Taipa, Peoples R China
关键词
SOLID LIPID NANOPARTICLE; DELIVERY; NANOTECHNOLOGY; BIOAVAILABILITY; PROLIPOSOME; LIPOSOMES;
D O I
10.1186/1749-8546-6-20
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Oleanolic acid (OA) is a natural triterpenoid possessing anti-inflammatory, antitumor, antiviral, hepatoprotective and antihyperlipidemic effects. Research on the pharmacological activities and clinical applications of OA has made significant progress in the past decade, particularly in the areas such as isolation and purification, chemical modifications, pharmacological research, toxicity studies and clinical use of OA. However, due to its poor aqueous solubility, instability and low bioavailability, OA's clinical applications are still rather limited. Recently, nanoparticulate drug delivery as the biological dimension of nanotechnology has been developed, which may help generate useful formulations of OA for clinical applications. Nanoparticulate drug delivery system enhances the dissolution rate and bioavailability of OA, providing a feasible formulation method for clinical applications.
引用
收藏
页数:4
相关论文
共 37 条
[1]   USE OF FLUIDIZED-BED IN PROLIPOSOME MANUFACTURING [J].
CHEN, CM ;
ALLI, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (05) :419-419
[2]  
[陈洪轩 CHEN Hong-xuan], 2010, [中成药, Chinese Traditional Patent Medicine], V32, P569
[3]  
[陈亚军 Chen Yajun], 2006, [中国药学杂志, Chinese Pharmaceutical Journal], V41, P924
[4]   Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effect [J].
Chen, YJ ;
Liu, J ;
Yang, XL ;
Zhao, XL ;
Xu, HB .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (02) :259-264
[5]   Characteristics of submicron emulsions prepared by ultra-high pressure homogenisation: Effect of chilled or frozen storage [J].
Cortes-Munoz, M. ;
Chevalier-Lucia, D. ;
Dumay, E. .
FOOD HYDROCOLLOIDS, 2009, 23 (03) :640-654
[6]   Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix [J].
Grohganz, H ;
Tho, I ;
Brandl, M .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 59 (03) :439-448
[7]   A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption [J].
Hong, JY ;
Kim, JK ;
Song, YK ;
Park, JS ;
Kim, CK .
JOURNAL OF CONTROLLED RELEASE, 2006, 110 (02) :332-338
[8]   Purification of hydroxyanthraquinones and cinnamic acid from the roots of Rheum officinale Baill [J].
Huang, Yanyan ;
Sun, Ailing ;
Qi, Yuanying ;
Liu, Renmin .
JOURNAL OF SEPARATION SCIENCE, 2008, 31 (02) :283-287
[9]   Nanotechnology tools in pharmaceutical R&D [J].
Kumar, Challa S. S. R. .
MATERIALS TODAY, 2010, 12 :24-30
[10]   Micro- and nanocarrier-mediated lung targeting [J].
Kurmi, Balak D. ;
Kayat, Jitendra ;
Gajbhiye, Virendra ;
Tekade, Rakesh K. ;
Jain, Narendra K. .
EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (07) :781-794